We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

S9925: Collecting and Storing Samples From Patients With Lung Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00920010
First Posted: June 12, 2009
Last Update Posted: February 6, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
  Purpose

RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.


Condition Intervention
Lung Cancer Other: biologic sample preservation procedure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lung Cancer Specimen Repository Protocol, Ancillary

Resource links provided by NLM:


Further study details as provided by Southwest Oncology Group:

Primary Outcome Measures:
  • Establishment of a central lung cancer specimen repository to serve as a resource for current and future scientific studies [ Time Frame: From date of study activation to consolidation of specimen banks ]
  • Correlation of clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository [ Time Frame: From date of study activation to consolidation of specimen banks ]
  • Test of new hypotheses with the specimens in the repository [ Time Frame: From date of study activation to consolidation of specimen banks ]

Biospecimen Retention:   Samples With DNA
Fixed tissue in paraffin blocks or slides, slides of buccal brushings, fresh frozen tissue peripheral blood, serum, plasma, white blood cells, and sputum.

Enrollment: 2264
Study Start Date: September 2000
Study Completion Date: January 2013
Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
  • Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
  • Test new hypotheses with the specimens in the repository.

OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.

PROJECTED ACCRUAL: Not specified

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Lung cancer patients registered to SWOG lung protocols.
Criteria

DISEASE CHARACTERISTICS:

  • Enrolled on one of the following Southwest Oncology Group protocols:

    • SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124

PATIENT CHARACTERISTICS: Not specified

PRIOR CONCURRENT THERAPY: Not specified

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00920010


  Show 431 Study Locations
Sponsors and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Investigators
Study Chair: Wilbur A. Franklin, MD University of Colorado, Denver
  More Information

Responsible Party: Southwest Oncology Group
ClinicalTrials.gov Identifier: NCT00920010     History of Changes
Other Study ID Numbers: CDR0000078624
S9925 ( Other Identifier: SWOG )
U10CA032102 ( U.S. NIH Grant/Contract )
First Submitted: June 11, 2009
First Posted: June 12, 2009
Last Update Posted: February 6, 2015
Last Verified: February 2015

Keywords provided by Southwest Oncology Group:
non-small cell lung cancer
small cell lung cancer

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases